List of Figures

FIGURE 1 CLINICAL TRIALS IMAGING MARKET 16
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 20
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 20
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 6 DATA TRIANGULATION METHODOLOGY 22
FIGURE 7 CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT 2015 VS. 2020 (USD MILLION) 26
FIGURE 8 CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY 2015 VS. 2020 (USD MILLION) 26
FIGURE 9 CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER 2015 VS. 2020 (USD MILLION) 27
FIGURE 10 CLINICAL TRIALS IMAGING MARKET: GEOGRAPHIC SNAPSHOT (2015) 28
FIGURE 11 CLINICAL TRIALS IMAGING MARKET SIZE, BY REGION 2015 VS. 2020 (USD MILLION) 28
FIGURE 12 EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET GROWTH 30
FIGURE 13 SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015 31
FIGURE 14 ASIA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD 31
FIGURE 15 NORTH AMERICA MARKET SEGMENT HEADED TOWARD MATURITY 32
FIGURE 16 CLINICAL TRIALS IMAGING MARKET: BY PRODUCT 34
FIGURE 17 CLINICAL TRIALS IMAGING MARKET: BY MODALITY 35
FIGURE 18 CLINICAL TRIALS IMAGING MARKET: BY END USER 35
FIGURE 19 INCREASE IN R&D SPENDING WILL DRIVE THE CLINICAL TRIALS IMAGING MARKET 36
FIGURE 20 INCREASING R&D FUNDING BOOSTING GROWTH IN THE CLINICAL TRIALS IMAGING MARKET 37
FIGURE 21 NUMBER OF BIOTECHNOLOGY PATENTS, BY COUNTRY, 2012 40
FIGURE 22 CLINICAL TRIALS IMAGING MARKET SEGMENTATION, BY PRODUCT 44
FIGURE 23 CLINICAL TRIALS IMAGING SERVICES TO FORM THE LARGEST SEGMENT IN 2015 45
FIGURE 24 OPERATIONAL IMAGING TO FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE FORECAST PERIOD 46
FIGURE 25 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE CLINICAL TRIALS IMAGING SERVICES MARKET IN 2015 47
FIGURE 26 ASIA TO BE THE FASTEST-GROWING SEGMENT OF THE OPERATIONAL IMAGING MARKET IN THE FORECAST PERIOD 48
FIGURE 27 NORTH AMERICA TO FORM THE LARGEST SEGMENT OF THE READ ANALYSIS MARKET IN 2015 50
FIGURE 28 ASIA TO FORM THE FASTEST-GROWING SEGMENT OF THE SYSTEM AND TECHNICAL SUPPORT MARKET IN THE FORECAST PERIOD 52
FIGURE 29 NORTH AMERICA TO COMMAND LARGEST SHARE OF THE TRIAL DESIGN CONSULTING MARKET IN THE FORECAST PERIOD 53
FIGURE 30 ASIA TO BE THE FASTEST-GROWING SEGMENT OF THE CLINICAL TRIALS IMAGING SOFTWARE MARKET IN THE FORECAST PERIOD 55
FIGURE 31 CLINICAL TRIALS IMAGING MARKET SEGMENTATION, BY MODALITY 58
FIGURE 32 CT SEGMENT TO COMMAND THE LARGEST SHARE OF THE CLINICAL TRIALS IMAGING MARKET IN 2015 58
FIGURE 33 NORTH AMERICA EXPECTED TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR CT IN 2015 60
FIGURE 34 ASIA TO WITNESS HIGHEST GROWTH IN THE CLINICAL TRIALS IMAGING MARKET FOR MRI IN THE FORECAST PERIOD 62
FIGURE 35 NORTH AMERICA EXPECTED TO FORM THE LARGEST REGIONAL SEGMENT FOR ULTRASOUND IN 2015 64
FIGURE 36 ASIA EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT FOR PET MARKET BETWEEN 2015 AND 2020 66
FIGURE 37 X-RAY MARKET IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 68
FIGURE 38 ECHOCARDIOGRAPHY MARKET IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 69
FIGURE 39 NORTH AMERICA DOMINATES THE MARKET FOR OTHER MODALITIES IN 2015 71
FIGURE 40 CLINICAL TRIALS IMAGING MARKET, BY END USER 74
FIGURE 41 CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER, 2015 (USD MILLION) 74
FIGURE 42 NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION 76
FIGURE 43 PHARMACEUTICAL COMPANIES SEGMENT TO WITNESS HIGHEST GROWTH IN ASIA IN 2015 77
FIGURE 44 NORTH AMERICA TO BE THE LARGEST SEGMENT OF THE BIOTECHNOLOGY COMPANIES SEGMENT IN 2020 79
FIGURE 45 NORTH AMERICA TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS IN 2020 81
FIGURE 46 NORTH AMERICA EXPECTED TO DOMINATE THE CLINICAL TRIALS IMAGING MARKET FOR CROS IN 2020 83
FIGURE 47 PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC & GOVERNMENT RESEARCH INSTITUTES END-USER SEGMENT 84
FIGURE 48 NORTH AMERICA DOMINATES THE MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES IN 2015 85
FIGURE 49 ASIA TO WITNESS THE HIGHEST GROWTH IN THE CLINICAL TRIALS IMAGING MARKET FOR OTHER END USERS IN THE FORECAST PERIOD 86
FIGURE 50 CLINICAL TRIALS IMAGING MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020 89
FIGURE 51 CLINICAL TRIALS IMAGING MARKET IN ASIA EXPECTED TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020 90
FIGURE 52 NORTH AMERICA: MARKET SNAPSHOT 92
FIGURE 53 U.S. FORMS THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015 93
FIGURE 54 SERVICES ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN NORTH AMERICA (2015) 94
FIGURE 55 OPERATIONAL IMAGING LARGEST SERVICES SEGMENT IN NORTH AMERICA (2015) 95
FIGURE 56 CT EXPECTED TO FORM FOR THE LARGEST MODALITY SEGMENT IN NORTH AMERICA IN 2015 96
FIGURE 57 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN NORTH AMERICA IN 2015 97
FIGURE 58 SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN EUROPE 2015 99
FIGURE 59 OPERATIONAL IMAGING ACCOUNTED FOR THE LARGEST SHARE IN THE EUROPEAN CLINICAL TRIALS IMAGING MARKET IN 2015 100
FIGURE 60 CT SEGMENT TO COMMAND THE LARGEST SHARE OF THE EUROPEAN CLINICAL TRIALS IMAGING MARKET IN 2015 101
FIGURE 61 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN EUROPE IN 2015 102
FIGURE 62 ASIA: MARKET SNAPSHOT 104
FIGURE 63 SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN ASIA (2015) 105
FIGURE 64 OPERATIONAL IMAGING TO FORM THE LARGEST SERVICES SEGMENT IN ASIA
IN 2015 106
FIGURE 65 CT SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL TRIALS IMAGING MARKET IN ASIA 107
FIGURE 66 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN ASIA IN 2015 108
FIGURE 67 SERVICES TO FORM THE LARGEST PRODUCT SEGMENT IN THE ROW IN 2015 110
FIGURE 68 OPERATIONAL IMAGING TO COMMAND THE LARGEST SHARE IN THE ROW CLINICAL TRIALS IMAGING MARKET (2015) 111
FIGURE 69 CT TO FORM THE LARGEST MODALITY SEGMENT IN ROW IN 2015 112
FIGURE 70 PHARMACEUTICAL COMPANIES TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2015 113
FIGURE 71 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE CLINICAL TRIALS IMAGING MARKET, 2013–2015 114
FIGURE 72 COMPANY SNAPSHOT: PAREXEL INTERNATIONAL CORPORATION 125
FIGURE 73 COMPANY SNAPSHOT: ICON PUBLIC LIMITED COMPANY 128
FIGURE 74 COMPANY SNAPSHOT: VIRTUALSCOPICS, INC. 133
FIGURE 75 COMPANY SNAPSHOT: IXICO PLC 137

 

List of Tables

TABLE 1 CLINICAL TRIALS IMAGING MARKET SUMMARY 25
TABLE 2 INCREASE IN R&D SPENDING IS PROPELLING THE GROWTH OF THE CLINICAL TRIALS IMAGING MARKET 39
TABLE 3 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS TO RESTRAIN MARKET GROWTH 39
TABLE 4 EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES 41
TABLE 5 HIGH COST OF CLINICAL TRIALS POSE A CHALLENGE FOR THE CLINICAL TRIALS IMAGING MARKET 42
TABLE 6 RISING DEMAND FOR MULTIMODALITY IMAGING TECHNOLOGY IN CLINICAL TRIALS IS A MAJOR TREND OBSERVED IN THIS MARKET 42
TABLE 7 CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT 2013–2020 (USD MILLION) 45
TABLE 8 CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE 2013–2020 (USD MILLION) 46
TABLE 9 CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY REGION 2013–2020 (USD MILLION) 47
TABLE 10 NORTH AMERICA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE BY COUNTRY, 2013–2020 (USD MILLION) 48
TABLE 11 CLINICAL TRIALS IMAGING MARKET SIZE FOR OPERATIONAL IMAGING BY REGION, 2013–2020 (USD MILLION) 49
TABLE 12 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OPERATIONAL IMAGING, BY COUNTRY, 2013–2020 (USD MILLION) 49
TABLE 13 CLINICAL TRIALS IMAGING MARKET SIZE FOR READ ANALYSIS, BY REGION 2013–2020 (USD MILLION) 51
TABLE 14 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR READ ANALYSIS, BY COUNTRY, 2013–2020 (USD MILLION) 51
TABLE 15 CLINICAL TRIALS IMAGING MARKET SIZE FOR SYSTEM AND TECHNICAL SUPPORT, BY REGION, 2013–2020 (USD MILLION) 52
TABLE 16 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR SYSTEM AND TECHNICAL SUPPORT, BY COUNTRY, 2013–2020 (USD MILLION) 53
TABLE 17 CLINICAL TRIALS IMAGING MARET SIZE FOR TRIAL DESIGN CONSULTING BY REGION, 2013–2020 (USD MILLION) 54
TABLE 18 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR TRIAL DESIGN CONSULTING, BY COUNTRY, 2013–2020 (USD MILLION) 54
TABLE 19 CLINICAL TRIALS IMAGING SOFTWARE MARKET SIZE, BY REGION 2013–2020 (USD MILLION) 55
TABLE 20 NORTH AMERICA: CLINICAL TRIALS IMAGING SOFTWARE MARKET SIZE BY COUNTRY, 2013–2020 (USD MILLION) 56
TABLE 21 CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY 2013–2020 (USD MILLION) 59
TABLE 22 CLINICAL TRIALS IMAGING MARKET SIZE FOR CT, BY REGION 2013–2020 (USD MILLION) 61
TABLE 23 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR CT BY COUNTRY, 2013–2020 (USD MILLION) 61
TABLE 24 CLINICAL TRIALS IMAGING MARKET SIZE FOR MRI, BY REGION 2013–2020 (USD MILLION) 63
TABLE 25 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR MRI BY COUNTRY, 2013–2020 (USD MILLION) 63
TABLE 26 CLINICAL TRIALS IMAGING MARKET SIZE FOR ULTRASOUND, BY REGION 2013–2020 (USD MILLION) 65
TABLE 27 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ULTRASOUND BY COUNTRY, 2013–2020 (USD MILLION) 65
TABLE 28 CLINICAL TRIALS IMAGING MARKET SIZE FOR PET, BY REGION 2013–2020 (USD MILLION) 67
TABLE 29 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR PET BY COUNTRY, 2013–2020 (USD MILLION) 67
TABLE 30 CLINICAL TRIALS IMAGING MARKET SIZE FOR X-RAY, BY REGION 2013–2020 (USD MILLION) 68
TABLE 31 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR X-RAY BY COUNTRY, 2013–2020 (USD MILLION) 69
TABLE 32 CLINICAL TRIALS IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY BY REGION, 2013–2020 (USD MILLION) 70
TABLE 33 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2013–2020 (USD MILLION) 70
TABLE 34 CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER MODALITIES BY REGION, 2013–2020 (USD MILLION) 71
TABLE 35 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER MODALITIES, BY COUNTRY, 2013–2020 (USD MILLION) 72
TABLE 36 CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER 2013–2020 (USD MILLION) 75
TABLE 37 CLINICAL TRIALS IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES BY REGION, 2013–2020 (USD MILLION) 77
TABLE 38 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2013–2020 (USD MILLION) 78
TABLE 39 CLINICAL TRIALS IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES BY REGION, 2013–2020 (USD MILLION) 79
TABLE 40 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2013–2020 (USD MILLION) 80
TABLE 41 CLINICAL TRIALS IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2013–2020 (USD MILLION) 81
TABLE 42 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2013–2020 (USD MILLION) 82
TABLE 43 CLINICAL TRIALS IMAGING MARKET SIZE FOR CROS, BY REGION 2013–2020 (USD MILLION) 83
TABLE 44 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR CROS BY COUNTRY, 2013–2020 (USD MILLION) 84
TABLE 45 CLINICAL TRIALS IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013–2020 (USD MILLION) 85
TABLE 46 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2013–2020 (USD MILLION) 86
TABLE 47 CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER END USERS, BY REGION, 2013–2020 (USD MILLION) 87
TABLE 48 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013–2020 (USD MILLION) 87
TABLE 49 CLINICAL TRIALS IMAGING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 89
TABLE 50 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY COUNTRY 2013–2020 (USD MILLION) 93
TABLE 51 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT 2013–2020 (USD MILLION) 94
TABLE 52 NORTH AMERICA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE BY TYPE, 2013-2020 (USD MILLION) 95
TABLE 53 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY 2013–2020 (USD MILLION) 96
TABLE 54 NORTH AMERICA: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER 2013–2020 (USD MILLION) 97
TABLE 55 EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT 2013–2020 (USD MILLION) 99
TABLE 56 EUROPE: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE 2013-2020 (USD MILLION) 100
TABLE 57 EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY 2013–2020 (USD MILLION) 101
TABLE 58 EUROPE: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER 2013–2020 (USD MILLION) 102
TABLE 59 ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT 2013–2020 (USD MILLION) 105
TABLE 60 ASIA: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE 2013-2020 (USD MILLION) 106
TABLE 61 ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY 2013–2020 (USD MILLION) 107
TABLE 62 ASIA: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER 2013–2020 (USD MILLION) 108
TABLE 63 ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY PRODUCT 2013–2020 (USD MILLION) 110
TABLE 64 ROW: CLINICAL TRIALS IMAGING SERVICES MARKET SIZE, BY TYPE 2013-2020 (USD MILLION) 111
TABLE 65 ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY MODALITY 2013–2020 (USD MILLION) 112
TABLE 66 ROW: CLINICAL TRIALS IMAGING MARKET SIZE, BY END USER 2013–2020 (USD MILLION) 113
TABLE 67 RANK OF COMPANIES IN THE GLOBAL CLINICAL TRIALS IMAGING MARKET, 2015 115
TABLE 68 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY ADOPTED BY PLAYERS BETWEEN JANUARY 2013 AND AUGUST 2015 116
TABLE 69 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2015 117
TABLE 70 ACQUISITIONS, 2013–2015 118
TABLE 71 NEW PRODUCT AND SERVICE LAUNCHES & PRODUCT UPGRADES, 2013–2015 119
TABLE 72 EXPANSIONS, 2013–2015 120
TABLE 73 OTHER DEVELOPMENTS, 2013–2015 121
TABLE 74 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND AUGUST 2015 122